Navigation Links
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
Date:10/29/2009

FRANKLIN, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that it has made significant advances to the development of its needle-free Symphony tCGM biosensor. The biosensor replaces the prototype two-piece biosensor used in earlier clinical trials and is designed to offer a one-piece, cost-effective, single-use biosensor with improved performance for use by consumers and healthcare providers.

"We are extremely pleased to announce this next step in the product development work on our one-piece biosensor, a critical component of Symphony, our needle-free, continuous glucose monitoring technology," stated Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics. "This next generation one-piece biosensor introduces new materials and a more effective geometrical construction and replaces the prior prototype two-piece biosensor used in earlier clinical trials. We believe that this new one-piece design will significantly reduce manufacturing costs, enabling the Company to offer a low-cost product. We also believe that this design will lead to improved continuous monitoring performance since a one-piece biosensor eliminates a primary source of the motion artifact seen with the earlier prototype two-piece biosensor. We look forward to testing this new and improved biosensor in a clinical trial in the near term and confirming the performance attributes observed in internal testing."

The new one-piece biosensor utilizes new materials and effective geometry design. It is intended to be a cost-effective product that allows for advanced continuous glucose monitoring performance for consumers and healthcare providers.

About Ec
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
2. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
3. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
4. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
5. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
6. Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
7. Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
8. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
9. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
10. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
11. Prime Therapeutics Receives 2010 TIPPS Certification for Adherence to High Transparency Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Calif. , May 22, 2015 /PRNewswire/ ... the Company has commenced termination of its ... brodalumab with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... inhibitor, is in development for patients with ... spondyloarthritis.  The decision was based on events ...
(Date:5/22/2015)... ORLANDO, Fla. , May 22, 2015 ... Copay Assistance Program. This program provides financial assistance for ... "We are pleased to announce the addition of the ... programs," stated Mark McGreevy , executive director. "With ... mission and vision of a world where no one ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Inc. (Nasdaq: MSON ), a developer of minimally ... used for the ablation of tumors and worldwide for ... first quarter ended September 30, 2009 financial results on ... President and Chief Executive Officer and Richard Zaremba, Senior ...
... Ind., Nov. 12 Zimmer Holdings, Inc. (NYSE: ZMH ... sell $1.0 billion of its senior unsecured notes in an ... due 2019 and $500.0 million of 5.75% notes due 2039. ... above their Treasury benchmark, and the 30-year notes were priced ...
Cached Medicine Technology:Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern 2Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
(Date:5/22/2015)... (PRWEB) May 22, 2015 Family, friends, ... Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on ... The luncheon began after Grand Rounds in the hospital’s ... waited anxiously outside the auditorium, trying to keep the ... but if he sees me, he’ll know something is ...
(Date:5/22/2015)... R.I. (PRWEB) May 22, 2015 Memorial Day ... Amica Insurance is offering some tips to help ... Safety Council, there will be 383 traffic fatalities this Memorial ... from the National Highway Traffic Safety Association: , ... in the vehicle is wearing a seatbelt, whether they’re driving ...
(Date:5/22/2015)... 2015 Coco Libre, the Official Coconut Water ... Record at the 104th running of the race. On Sunday, ... served 315 people in one hour—one person about every 10 ... so true to the heart of the Bay Area, so ... luge to the finish line only made sense,” said Jennifer ...
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2
... By Serena Gordon HealthDay Reporter , FRIDAY, ... helped prevent or slow the progression of type 1 diabetes ... too early to say if the results might apply to ... the immune system,s response to newly developing diabetes, and reduced ...
... HealthDay Reporter , FRIDAY, May 11 (HealthDay News) ... health, reducing stress levels and contributing to better focus, a ... Irvine, and the U.S. Army found that a group of ... five days experienced more natural, variable heart rates and switched ...
... a concentrated, highly targeted dose of radiation to the ... area, with no adverse effects on survival and a ... the ten-year results of a randomised trial, Professor Csaba ... Institute of Oncology, Budapest, will tell the World Congress ...
... KU Leuven, succeeded in undoing the effect of one ... vitamin K2. His discovery gives hope to Parkinson,s patients. ... Northern Illinois University (US) and will be published this ... Science ., "It appears from our research that administering ...
... Denise Mann HealthDay Reporter , THURSDAY, May 10 ... marrow stem cells to enhance their healing potential may help ... small study suggests. Researchers developed the treatment by ... process helped increase the amount of immune cells and stem ...
... Inducing labor after a woman has been pregnant for more ... before, during or shortly after birth without increasing the need ... born after induced labor were also more likely to require ... led by Sarah Stock of the School of Women and ...
Cached Medicine News:Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 2Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 3Health News:'Email Vacations' Boost Job Productivity, Lower Stress: Study 2Health News:'Email Vacations' Boost Job Productivity, Lower Stress: Study 3Health News:Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer 2Health News:Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer 3Health News:Vitamin K2: New hope for Parkinson's patients? 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 3Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2
This is an economical (portable) microtome designed for fast and accurate sectioning. The specimen rise is automatic and accurate with each handle movement. Section thickness from 5 to 40 microns. ...
Disposable Feather Blades, 50 per pack...
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Medicine Products: